The Connection Between MS and Hypothyroidism

Multiple sclerosis and hypothyroidism are connected on several levels: they share genetic risk factors, they co-occur in the same patients more often than chance would predict, and certain MS treatments can directly trigger thyroid disease. The relationship is not one of cause and effect in either direction, but rather two conditions drawing from the same well of immune system dysfunction. Understanding where they overlap matters for diagnosis, treatment decisions, and day-to-day symptom management.

How Often the Two Conditions Overlap

Thyroid disease, including hypothyroidism, shows up more frequently in people with MS than in the general population. A cross-sectional study of newly diagnosed MS patients found significantly higher rates of abnormal thyroid-stimulating hormone (TSH) levels compared to controls, with the difference especially pronounced in women.¹ A separate study examining an MS cohort found increased prevalence of both Graves’ disease and Hashimoto’s thyroiditis, though the Hashimoto’s association lost statistical significance after adjusting for the age and sex makeup of the group.² That adjustment matters because both conditions disproportionately affect women, which inflates the raw overlap numbers.

Broader reviews of MS comorbidities consistently list thyroid disease as one of the autoimmune conditions that clusters with MS, alongside type 1 diabetes and inflammatory bowel disease.³ The overlap is real, but it is worth keeping in perspective: most people with MS will never develop thyroid problems, and most people with hypothyroidism will never develop MS. The connection is statistical, not deterministic.

Shared Genetic Roots

The most convincing explanation for why MS and autoimmune thyroid disease travel together is that they share segments of genetic architecture. A study using genome-wide association data identified 46 common genetic susceptibility pathways between MS and autoimmune thyroid diseases, along with 29 hub genes that were active in both conditions. Among the shared pathways were those involved in how certain immune cells develop and function.⁴

One well-studied example is a variant in the CD226 gene. The Ser307 allele of this gene, which affects how T cells communicate and activate, has been associated with susceptibility to MS, type 1 diabetes, and potentially autoimmune thyroid disease and rheumatoid arthritis.⁵ This is a pattern researchers see across autoimmune diseases broadly: the same handful of immune-regulating gene variants make people vulnerable to not just one condition but a cluster of them. You do not inherit “MS genes” and separately inherit “thyroid genes.” You inherit immune system wiring that, under the right circumstances, can misfire in multiple directions.

Environmental and Hormonal Patterns

Genetics load the gun, but environment and hormones help pull the trigger. One hypothesis ties several autoimmune diseases together through a shared mechanism involving low vitamin D levels, Epstein-Barr virus infection, and a shortage of a specific type of immune cell (CD8+ T cells). The proposal is that vitamin D deficiency, which is more common at higher latitudes, weakens the immune system’s ability to control Epstein-Barr virus, and this poor viral control eventually leads to autoimmune attacks. Both MS and Hashimoto’s thyroiditis appear on the list of chronic autoimmune diseases that share this pattern of CD8+ T-cell deficiency.⁶

Sex hormones add another layer. Autoimmune thyroid diseases are far more common in women than in men, and the relationship between sex hormones and immune function is considered a major reason for that disparity.⁷ MS also affects women at roughly two to three times the rate it affects men. The fact that both conditions lean so heavily female suggests that estrogen and other sex hormones play a role in immune regulation that goes beyond any single disease. If you are a woman with one autoimmune condition, the same hormonal environment that contributed to it also makes other autoimmune conditions somewhat more likely.

When Symptoms Look Alike

One of the most frustrating aspects of living with both conditions is that they produce overlapping symptoms. Hypothyroidism commonly causes fatigue, depressed mood, difficulties with memory and executive function, sleepiness, anxiety, and confusion. MS produces many of those same problems, especially fatigue and cognitive fog, through entirely different mechanisms. The practical result is that it can be genuinely difficult to tell which condition is responsible for a given symptom on any given day.

This overlap creates a diagnostic trap. A person with known MS who develops worsening fatigue and mental cloudiness may assume it is their MS progressing, when in reality their thyroid has quietly become underactive. Conversely, someone initially diagnosed with hypothyroidism might have early neurological symptoms attributed to thyroid dysfunction when MS is actually developing. The symptoms of hypothyroidism are treatable with thyroid hormone replacement, so catching an underactive thyroid in someone with MS can meaningfully improve quality of life even if it does nothing for the MS itself. Routine thyroid screening is particularly worthwhile for people already diagnosed with MS, both because of the baseline elevated risk and because of the symptom masking that can delay recognition.

Alemtuzumab and Treatment-Induced Thyroid Disease

Perhaps the most direct link between MS and thyroid disease comes not from shared biology but from a specific treatment. Alemtuzumab, a potent drug used for relapsing-remitting MS, works by depleting certain immune cells. As those cells rebuild, the immune system sometimes misfires and attacks the thyroid. This is not a rare side effect. In a phase 2 trial with a median follow-up of about five years, roughly a third of alemtuzumab-treated patients developed thyroid dysfunction, compared to about 6.5% of patients on a standard interferon treatment. Graves’ hyperthyroidism was the most common form, occurring in about 22% of the alemtuzumab group, followed by hypothyroidism at about 7%.⁸

Phase 3 trials painted an even starker picture, with the five-year incidence of thyroid adverse events climbing to roughly 40%.⁹ A longer-term analysis found that over six years, 42% of alemtuzumab-treated patients experienced at least one thyroid event. Most of these were classified as nonserious, but about 5% experienced serious thyroid events, and hyperthyroidism was the most common presentation among serious cases.¹⁰

For patients on alemtuzumab, thyroid monitoring is not optional. Clinicians are advised to check thyroid function regularly for several years after treatment. The good news is that thyroid dysfunction, once caught, is usually manageable with standard treatments: medication for an overactive thyroid or hormone replacement for an underactive one. The development of thyroid problems did not appear to erase the quality-of-life benefits that alemtuzumab provided for MS symptoms overall.¹⁰ Still, the near coin-flip odds of developing thyroid disease are something patients and their neurologists should weigh carefully when choosing among MS therapies.

Does Having Both Change the Course of MS?

A reasonable worry for anyone with both MS and autoimmune thyroid disease is whether the combination makes MS worse. The reassuring answer, based on the available evidence, is that it does not appear to. A retrospective cohort study looking at patients with both autoimmune thyroiditis and MS found no statistical differences in relapse number, MRI activity over five years, disability scores, or the likelihood of achieving “no evidence of disease activity” status.¹¹ A separate single-center cohort study reached essentially the same conclusion, finding no significant difference in clinical, radiological, or laboratory characteristics between MS patients with and without thyroid conditions.¹²

This is a case where the shared genetic ground between two conditions does not translate into one making the other worse once both are present. Autoimmune thyroiditis appears to have a neutral effect on the trajectory of MS. That said, untreated hypothyroidism will absolutely make someone feel worse regardless of their MS status, so the practical takeaway is to manage the thyroid condition aggressively even if it is not directly worsening the neurological disease.

Thyroid Hormones and Myelin Repair

While the epidemiological and genetic connections get most of the clinical attention, there is a separate and fascinating line of research connecting thyroid hormones to the core damage that MS causes. MS destroys myelin, the insulating sheath around nerve fibers. Thyroid hormones play a key role in how the body builds and repairs that sheath. During normal development, thyroid hormone drives the maturation of oligodendrocytes, the cells responsible for producing myelin.¹³

This has led researchers to ask whether thyroid hormone treatment could help promote remyelination in MS. In animal models of MS-like disease, administering the active form of thyroid hormone (T3) led to markedly improved remyelination in the brain, with evidence that the hormone was prompting precursor cells to mature into myelin-producing oligodendrocytes.¹⁴ Another animal study found that thyroid hormone (T4) increased markers for both oligodendrocyte precursors and mature oligodendrocytes in the spinal cord.¹⁵

The results in animal models have been consistently encouraging. Mice with an MS-like disease given thyroid hormone showed reduced clinical disease, more normally myelinated axons, fewer degenerating axons, and more surviving oligodendrocytes. The hormone also protected cultured oligodendrocytes from cell death in the lab.¹⁶ In another study, T3-treated animals had faster nerve impulse conduction (closer to healthy control values) and normalized levels of key proteins in their nerve fibers, without showing signs of whole-body hyperthyroidism.¹⁷

The catch is that flooding the whole body with thyroid hormone to fix the brain is a terrible idea. Excess thyroid hormone causes heart problems, bone loss, and a host of other complications. Researchers are instead pursuing thyroid-hormone-like compounds (thyromimetics) that could act selectively in the central nervous system without the systemic side effects.¹³ This work is still in early stages, but it raises a provocative question: in MS patients who also have hypothyroidism, could their thyroid deficiency be quietly sabotaging whatever natural remyelination capacity their brain retains? No clinical trial has answered that question directly, but the animal evidence makes it biologically plausible and adds urgency to keeping thyroid levels well-controlled in people with MS.

Family History and Pediatric MS

The genetic connection between MS and thyroid disease extends beyond an individual patient. Families of children diagnosed with pediatric MS show increased rates of autoimmune disorders, including thyroid conditions, compared to the general population.¹⁸ This clustering within families suggests that the shared genetic susceptibility discussed earlier is not just a statistical abstraction but something that runs through family trees in observable ways.

For parents of a child with MS, this does not mean that thyroid disease is inevitable for other family members. But it does mean that a family history heavy in autoimmune conditions, whether thyroid, MS, type 1 diabetes, or others, is a signal worth mentioning to a doctor. Earlier screening and awareness can catch thyroid problems before they cause months of unexplained fatigue or mood changes. And for pediatric MS patients themselves, routine thyroid monitoring is prudent from early in their disease, since the same immune vulnerability that led to MS could quietly set up thyroid trouble down the road.

Why the Female Predominance Matters

Both MS and autoimmune hypothyroidism are far more common in women, and this is not a coincidence. The relationship between sex hormones and immune function means that estrogen and other female hormones influence how vigorously the immune system responds, and that heightened responsiveness cuts both ways: it provides better defense against infection but raises the risk of the immune system mistakenly attacking the body’s own tissues.⁷

For women with MS, this hormonal backdrop makes thyroid screening especially relevant. The cross-sectional data on newly diagnosed MS patients showed the elevated rate of thyroid dysfunction was driven primarily by the female subgroup.¹ Pregnancy adds another dimension, since both MS activity and thyroid function can shift during and after pregnancy. A woman with MS who develops postpartum fatigue, depression, or cognitive fog should have her thyroid checked before those symptoms are attributed entirely to the neurological disease or to normal postpartum adjustment. A simple blood test can identify a treatable problem hiding behind more familiar explanations.